Hyperthyroidism has several causes, with Graves' disease, toxic thyroid nodules and thyroiditis among the principal causes. Other possibilities include excessive iodine exposure, excessive thyroid-hormone medication and, much more rarely, disorders involving the pituitary gland or hormone-producing tumours outside the thyroid. The causes can be grouped according to whether the thyroid is actively synthesising excessive hormone or whether excessive hormone is entering the circulation by another mechanism. Graves' disease and autonomous nodules increase thyroid-hormone synthesis. Thyroiditis generally causes leakage of preformed hormone. Medication-related thyrotoxicosis introduces hormone from outside the gland. Correctly distinguishing these mechanisms is important because treatment differs substantially between them.
Graves' disease is an autoimmune cause in which the immune system produces antibodies that stimulate the thyroid's TSH receptor. Instead of the pituitary being the main driver of thyroid stimulation, the antibodies act as persistent receptor stimulators. Thyroid cells consequently increase hormone synthesis and secretion, often causing diffuse enlargement of the gland. The antibodies can also affect tissues around the eyes, producing thyroid eye disease. The precise cause of Graves' disease is not completely understood, but genetic susceptibility interacts with environmental and immune factors. Family history is relevant, and smoking increases the risk of developing or worsening thyroid eye disease.
Autonomous thyroid nodules cause hyperthyroidism when thyroid tissue begins producing hormones independently of normal TSH regulation. A toxic adenoma involves a single hyperfunctioning nodule, whereas toxic multinodular goitre involves multiple independently functioning areas. These nodules are usually benign rather than malignant. They occur more commonly in older adults and may develop in a previously enlarged or nodular thyroid. Because autonomous tissue continues functioning despite suppressed TSH, the normal feedback mechanism cannot fully stop hormone production. Imaging can help determine whether thyroid activity is diffuse, focal or multifocal, which contributes to identifying the cause of biochemical hyperthyroidism.
Thyroiditis causes hyperthyroidism through release of stored thyroid hormone rather than necessarily through increased synthesis. Subacute thyroiditis can follow an inflammatory illness and is often associated with a painful thyroid. Painless thyroiditis and postpartum thyroiditis can produce similar biochemical changes without significant pain. The excess hormone generally represents material that was already synthesised and stored in the gland. Consequently, the hyperthyroid phase is often temporary. Once the stored hormone is depleted, thyroid function can become low before recovering. Some patients develop permanent hypothyroidism. This temporal progression means that thyroiditis can produce apparently contradictory thyroid-function states over time without representing two unrelated diseases.
Iodine can produce hyperthyroidism in susceptible people because it is a fundamental substrate for thyroid-hormone synthesis. Large iodine exposures can occur through certain medicines, supplements, seaweed products and iodine-containing medical preparations. In some people, particularly those with pre-existing autonomous thyroid tissue, an increased iodine supply can provide the substrate required for excessive hormone synthesis. This phenomenon is often described as iodine-induced hyperthyroidism. Iodine-containing contrast used in medical imaging can also be relevant in selected circumstances. The relationship is not straightforward because iodine is essential for normal thyroid function and excessive exposure affects people differently depending on their underlying thyroid physiology.
Excessive thyroid-hormone medication is another cause of thyrotoxicosis. A person receiving levothyroxine or another thyroid-hormone preparation can develop excessive circulating hormone if the dose is too high or if circumstances change the body's hormone requirements. This is technically different from a thyroid gland becoming intrinsically overactive because the excess hormone is supplied externally. Laboratory results can resemble endogenous hyperthyroidism, so medication history is important. Some supplements may also contain thyroid hormones or hormone-like substances without the user appreciating their pharmacological significance. Clinical assessment therefore includes prescription medicines, over-the-counter products and supplements when investigating unexplained excess thyroid-hormone activity.
Rare causes include disorders involving the pituitary gland. A TSH-secreting pituitary tumour can produce inappropriately high TSH, stimulating the thyroid and causing excessive thyroid-hormone production. This is unusual and differs from typical primary hyperthyroidism, in which TSH is suppressed by negative feedback. Rare hormone-producing tumours outside the thyroid can also produce substances that stimulate thyroid function or contribute to thyrotoxicosis. These conditions require specialised endocrine investigation because the usual assumption that low TSH accompanies hyperthyroidism does not apply in every unusual mechanism. Interpretation therefore depends on the entire biochemical pattern and clinical context rather than a single laboratory value.
The distinction between hyperthyroidism and thyrotoxicosis is particularly important when discussing causes. Hyperthyroidism means the thyroid gland itself is producing too much thyroid hormone, whereas thyrotoxicosis means that tissues are exposed to excessive thyroid-hormone activity regardless of the source. Graves' disease and toxic nodules are genuine hyperthyroid states. Thyroiditis can cause thyrotoxicosis without sustained increased hormone synthesis. Excessive thyroid medication can cause thyrotoxicosis without an intrinsically overactive thyroid. Recognising this distinction prevents inappropriate treatment and explains why different diagnostic tests may be needed. Blood tests establish the biochemical state, while antibody tests, imaging, medication history and the clinical course help determine its origin.
